Sickle cell disease; annual review of medication and treatment, report.

Department of Medical Assistance Services; annual review of medication and treatment for sickle cell disease; report. Directs the Department of Medical Assistance Services to conduct an annual review of all medications and forms of treatment for sickle cell disease, and services for enrollees with a diagnosis of sickle cell disease, that are eligible for coverage under the state plan for medical assistance services. The bill requires the Department to report its findings and recommendations by November 15 each year to the Chairmen of the House Committee of Health, Welfare and Institutions and the Senate Committee on Education and Health and to the Joint Commission on Health Care.